Form S-1/A TuHURA Biosciences Inc For: 16 January
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TuHURA Biosciences Inc (HURA)
TuHURA Biosciences Inc stock price live, this page displays NASDAQ HURA stock exchange data. View the HURA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TuHURA Biosciences Inc real time stock price chart below.
What Is the TuHURA Biosciences Inc Stock Price Today?
The TuHURA Biosciences Inc stock price today is 0.6677.
What Is the Stock Symbol for TuHURA Biosciences Inc?
The stock symbol for TuHURA Biosciences Inc is "HURA."
What Stock Exchange Does TuHURA Biosciences Inc Trade On?
TuHURA Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is TuHURA Biosciences Inc a Good Stock to Buy?
Determining whether TuHURA Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HURA quote. (ISIN: US8989201038)
What Is the TuHURA Biosciences Inc Stock Price Today?
The TuHURA Biosciences Inc stock price today is 0.6677.
What Is the Stock Symbol for TuHURA Biosciences Inc?
The stock symbol for TuHURA Biosciences Inc is "HURA."
What Stock Exchange Does TuHURA Biosciences Inc Trade On?
TuHURA Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is TuHURA Biosciences Inc a Good Stock to Buy?
Determining whether TuHURA Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HURA quote. (ISIN: US8989201038)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6561
0.7000
52 wk Range
0.6561
5.2700
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.65610.7000
52 wk Range
0.65615.2700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HURA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
8.6250
Upside
+1,191.75%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Delmar Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form S-1/A TuHURA Biosciences Inc For: 31 December
- Investing.com
- Form S-1/A TuHURA Biosciences Inc For: 16 January
- Investing.com
- Delmar Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form S-1/A TuHURA Biosciences Inc For: 31 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
TuHURA Biosciences Inc Company Profile
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company’s lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-specific antibody-peptide conjugates and antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. In addition, the company is also developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc. in December 2023. The company was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.
Compare HURA to Peers and Sector
Metrics to compare | HURA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHURAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −3.9x | −0.6x | |
PEG Ratio | 0.01 | 0.09 | 0.00 | |
Price/Book | 2.5x | 5.8x | 2.6x | |
Price / LTM Sales | - | 199.8x | 3.4x | |
Upside (Analyst Target) | - | 53.4% | 42.0% | |
Fair Value Upside | Unlock | −10.2% | 5.0% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.6250
(+1,191.75% Upside)
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
-0.14 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the TuHURA Biosciences (HURA) Stock Price Today?
The TuHURA Biosciences stock price today is 0.6677
What Stock Exchange Does TuHURA Biosciences Trade On?
TuHURA Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for TuHURA Biosciences?
The stock symbol for TuHURA Biosciences is "HURA."
What Is the TuHURA Biosciences Market Cap?
As of today, TuHURA Biosciences market cap is 40.54M.
What Is TuHURA Biosciences's Earnings Per Share (TTM)?
The TuHURA Biosciences EPS (TTM) is -0.66.
From a Technical Analysis Perspective, Is HURA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has TuHURA Biosciences Stock Split?
TuHURA Biosciences has split 5 times.
How Many Employees Does TuHURA Biosciences Have?
TuHURA Biosciences has 19 employees.
What is the current trading status of TuHURA Biosciences (HURA)?
As of Jan 25, 2026, TuHURA Biosciences (HURA) is trading at a price of 0.6677, with a previous close of 0.6793. The stock has fluctuated within a day range of 0.6561 to 0.7000, while its 52-week range spans from 0.6561 to 5.2700.
What Is TuHURA Biosciences (HURA) Price Target According to Analysts?
The average 12-month price target for TuHURA Biosciences is USD8.6250, with a high estimate of USD10 and a low estimate of USD7.5. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,191.75% Upside potential.
What Is the HURA Premarket Price?
HURA's last pre-market stock price is 0.6900. The pre-market share volume is 3,630.0000, and the stock has decreased by 0.0107, or 1.5800%.
What Is the HURA After Hours Price?
HURA's last after hours stock price is 0.6737, the stock has decreased by 0.0060, or 0.9000%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.